Longevity Health Holdings, Inc.

Longevity Health Holdings, Inc. is a bio-aesthetics company that develops, manufactures, and markets cosmetic skincare and haircare products. The company uses Carmell Secretome and Elevai Exosomes to support skin and hair health. Carmell Secretome is made up of growth factors, proteins, and peptides derived from allogeneic human platelets. Elevai Exosomes contain growth factors, cytokines, peptides, and other small molecules that play a role in the body's natural healing process. Longevity Health Holdings also develops a microemulsion formulation designed to deliver both lipophilic and hydrophilic ingredients without using the "Foul Fourteen," which are 14 potentially harmful excipients often used by other companies to give cosmetic products texture, stability, and other physical and chemical properties. The company has a licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. Founded in 2008, Longevity Health Holdings, Inc. was formerly known as Carmell Corporation and changed its name in March 2025. The company is headquartered in Pittsburgh, Pennsylvania.